InvestSMART

Anatara Lifesciences Ltd (ASX: ANR) - Announcements

- Current share price for ANR : $0.008

ASX company news and announcements for Anatara Lifesciences Ltd (ANR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anatara Lifesciences Ltd (ANR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anatara Lifesciences Ltd (ANR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anatara Lifesciences Ltd (ANR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Letter to Optionholders 3 Nov 2023 9:07AM $0.030 $0.008 fallen by 73.33%
$3 Proposed issue of securities - ANR 3 Nov 2023 9:07AM $0.030 $0.008 fallen by 73.33%
$3 Cleansing Notice 3 Nov 2023 9:06AM $0.030 $0.008 fallen by 73.33%
$3 Anatara launches a partially underwritten Entitlement Offer 3 Nov 2023 9:00AM $0.030 $0.008 fallen by 73.33%
$3 Trading Halt 1 Nov 2023 9:34AM $0.030 $0.008 fallen by 73.33%
$3 Appendix 4C & Q1 FY24 Activities Report 31 Oct 2023 5:07PM $0.030 $0.008 fallen by 73.33%
$3 Webinar Investor Presentation 19 Oct 2023 9:59AM $0.025 $0.008 fallen by 68%
$3 IBS Trial Results Webinar and QA 17 Oct 2023 2:18PM $0.029 $0.008 fallen by 72.41%
$3 Anatara IBS trial positive secondary endpoint data analysis 17 Oct 2023 9:13AM $0.029 $0.008 fallen by 72.41%
$3 Appendix 4G and Corporate Governance Statement 16 Oct 2023 2:23PM $0.029 $0.008 fallen by 72.41%
$3 Annual Report to shareholders 16 Oct 2023 2:22PM $0.029 $0.008 fallen by 72.41%
$3 Trading Halt 16 Oct 2023 9:29AM $0.029 $0.008 fallen by 72.41%
$3 Notice of Annual General Meeting/Proxy Form 9 Oct 2023 3:25PM $0.030 $0.008 fallen by 73.33%
$3 Final Director's Interest Notice 2 Oct 2023 7:21PM $0.028 $0.008 fallen by 71.43%
$3 Initial Director's Interest Notice 2 Oct 2023 9:09AM $0.028 $0.008 fallen by 71.43%
$3 Anatara Board Changes 2 Oct 2023 8:34AM $0.028 $0.008 fallen by 71.43%
$3 ANR announces Positive Results from Stage 1 of IBS trial 28 Sep 2023 10:06AM $0.034 $0.008 fallen by 76.47%
$3 Trading Halt 26 Sep 2023 12:31PM $0.034 $0.008 fallen by 76.47%
$3 Pause in Trading 26 Sep 2023 12:14PM $0.034 $0.008 fallen by 76.47%
$3 Anatara Annual General Meeting & Director Nominations 19 Sep 2023 4:23PM $0.034 $0.008 fallen by 76.47%
$3 IBS clinical trial Stage 1 patients finalised 31 Aug 2023 8:10AM $0.028 $0.008 fallen by 71.43%
$3 Appendix 4E & Audited Financial Statements 30 June 2023 24 Aug 2023 9:33AM $0.034 $0.008 fallen by 76.47%
$3 $923,235 in R&D tax incentive received 14 Aug 2023 9:29AM $0.031 $0.008 fallen by 74.19%
$3 Notification regarding unquoted securities - ANR 1 Aug 2023 4:33PM $0.035 $0.008 fallen by 77.14%
$3 Appendix 4C & Q4 FY23 Activities Report 31 Jul 2023 4:24PM $0.035 $0.008 fallen by 77.14%

151 - 175 of 540 results

Page 7 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.